معرفی
Freddi Andersson is a researcher affiliated with Lund University, Sweden, working within the Division of Clinical Chemistry and Pharmacology and the Lund University Cancer Centre (LUCC). His research contributes to the United Nations Sustainable Development Goals, particularly in Biomedical Laboratory Science and Pharmacology.
His work focuses on protease inhibition mechanisms and their role in melanoma progression. In 2017, Andersson co-authored a study published in the Journal of Biological Chemistry, examining how cystatin E/M influences legumain activity and melanoma cell migration. This research aligns with his broader interests in Cystatin M, Legumain, and Malignant Neoplasm.
Andersson is involved in a dissertation project titled Variants of cystatin C (2014–ongoing), collaborating with Principal Investigator Magnus Abrahamson and supervisor Anders Grubb. He also co-organized the Cellbiologi-BIMA15 course at Lund University in 2017. Contact details include email freddi.andersson@med.lu.se and phone numbers +46730475484 and +4646173456.
